About CSL

With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.

CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL's therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!

Job Description

Located in Parkville (Australia) and part of the Global R&D Technical Development (TD) team, this is a full-time permanent position. The successful candidate will be part of the team that provides the highest level of scientific expertise in immunology and virology to support innovation within this department. As the Director, Head of Virology and Immunology you will be responsible to deliver technical development of seed viruses to Seqirus worldwide and the programs to develop candidate vaccine viruses.

The position requires someone with industry leading expertise in managing large teams of scientists and/or other professional employees to drive Technical Development programs related to development of candidate viruses, yield improvements for vaccine platforms, introduction of new products and/or transfer of technology developed by Technical Development for Influenza and Products of National Significance.

To be successful in this role you will

• Be an expert in Influenza, virology and/or molecular biology
• Be the technical expert providing scientific and technical advice
• Provide direction, innovative solutions and ensure alignment within Global TD (which includes BioProcess Development, Analytical Development and LabOps/Project Management), R&D and Operations.
• Advise on the development of seasonal and pandemic influenza seed virus for both egg and cell platforms to ensure first to market, market requirements and expansion
• Have a PhD in a relevant scientific field e.g. Molecular Biology, Virology, Immunology.
• 12+ years of relevant experience in this field including 7+ years' experience at senior manager/executive level or higher in a large pharmaceutical company
• Have extensive experience managing financial budgets with business acumen to engage and influence internal and external stakeholders.

As an inspiring thought leader who is invested in the success of others and their development you will also be proactive and innovative with excellent communication skills to complement your scientific technical expertise.

If you are looking to develop your skills and shape the health of Australians, please apply.

Applications must address the selection criteria above and include a current CV, covering letter and reference number R-130305

Applications will close on Friday 30th April 2021

CSL advises that screening including; criminal history, medical assessment, confirmation of experience, stated qualifications and other relevant checks form a part of the candidate suitability evaluation process. Where applicable, this applies to current CSL employees. CSL employees must notify their current manager when selected for interview for any advertised internal vacancies.